Page last updated: 2024-08-16

ranitidine and Psoriasis

ranitidine has been researched along with Psoriasis in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (91.67)	18.2507
2000's	1 (8.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brünner, N; Christensen, IJ; Hansen, U; Kristensen, JK; Nielsen, HJ; Petersen, LJ; Svendsen, MN; Werther, K	1
Smith, KC	1
Bos, JD; Bossuyt, PM; Hulsmans, RF; Meinardi, MM; Velthuis, PJ; Verhaegh, ME; Witkamp, L	1
Hansen, U; Kristensen, JK; Nielsen, H; Nielsen, HJ; Petersen, LJ; Skov, PS	2
Bjerring, P; Heickendorff, L; Zachariae, H	1
Hansen, U; Kristensen, JK; Nielsen, HI; Nielsen, HJ; Petersen, LM; Skov, PS	1
Bos, JD; Bossuyt, PM; Hamminga, L; Johansen, UB; Karlsmark, T; Kuiters, GR; Meinardi, MM; Staberg, B; van Niel, JC; van't Veen, AJ; Zonneveld, IM	1
Alpsoy, E; Başaran, E; Cetin, L; Yilmaz, E	1
Andersen, M	1
Nielsen, HJ	1
Georgsen, J; Nielsen, H; Nielsen, HJ	1

Reviews

1 review(s) available for ranitidine and Psoriasis

Article	Year
Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations. Danish medical bulletin, 1991, Volume: 38, Issue:6 Topics: Cyclosporine; Histamine; Histamine Antagonists; Histamine H2 Antagonists; Humans; Methotrexate; Psoriasis; Ranitidine	1991

Trials

6 trial(s) available for ranitidine and Psoriasis

Article	Year
Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2002, Volume: 51, Issue:11 Topics: Adult; Aged; Biopsy; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Histamine H2 Antagonists; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Psoriasis; Ranitidine; Regional Blood Flow; Skin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis. Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:5 Pt 1 Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Ranitidine; Remission Induction; Time Factors	1993
Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial. The British journal of dermatology, 1995, Volume: 133, Issue:6 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Ranitidine; Severity of Illness Index; Time Factors	1995
Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study. Journal of the American Academy of Dermatology, 1997, Volume: 36, Issue:6 Pt 1 Topics: Adult; Double-Blind Method; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Psoriasis; Ranitidine	1997
High-dose ranitidine is ineffective in the treatment of psoriasis. The British journal of dermatology, 1997, Volume: 137, Issue:6 Topics: Adult; Double-Blind Method; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Psoriasis; Ranitidine; Severity of Illness Index; Treatment Failure	1997
Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta dermato-venereologica, 1998, Volume: 78, Issue:3 Topics: Case-Control Studies; CD4-CD8 Ratio; Female; Histamine; Histamine H2 Antagonists; Histamine Release; Humans; Immunohistochemistry; Male; Mast Cells; Psoriasis; Ranitidine; Severity of Illness Index; Skin; T-Lymphocytes; Treatment Outcome	1998

Other Studies

5 other study(ies) available for ranitidine and Psoriasis

Article	Year
Ranitidine useful in the management of psoriasis in a patient with acquired immunodeficiency syndrome. International journal of dermatology, 1994, Volume: 33, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Combined Modality Therapy; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Psoriasis; Ranitidine; Ultraviolet Therapy	1994
Plasma endothelin in psoriasis: possible relations to therapy and toxicity. Acta dermato-venereologica, 1996, Volume: 76, Issue:6 Topics: Acitretin; Cyclosporine; Endothelins; Humans; Hydroxyurea; Keratolytic Agents; Methotrexate; Psoriasis; Ranitidine	1996
[Clinical effect of ranitidine in psoriasis. An open prospective study]. Ugeskrift for laeger, 1997, Jan-27, Volume: 159, Issue:5 Topics: Adult; Aged; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Ranitidine	1997
[Exacerbation of psoriasis during treatment with H2 antagonists]. Ugeskrift for laeger, 1991, Jan-07, Volume: 153, Issue:2 Topics: Aged; Cimetidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Psoriasis; Ranitidine	1991
Ranitidine for improvement of treatment-resistant psoriasis. Archives of dermatology, 1991, Volume: 127, Issue:2 Topics: Adult; Female; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Ranitidine	1991